Suppliers / Cyndea Pharma, S.L

Cyndea Pharma, S.L

Spain 137 employees Updated 9 July 2026

Cyndea Pharma, S.L is a finished-dose manufacturer based in Spain. It appears in 28 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), EFDA (ET) and NAFDAC (NG). Its GMP standing is certified by ANVISA (Brazil), AEMPS (ES) and NAFDAC (NG), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 10 March 2022 as VAI.

0
active US DMFs
0
valid CEPs
6
registered plants 1 with an FDA FEI number
28
filings across 9 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 10 March 2022 VAI US FDA
  • 3 April 2019 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Olvega, United Arab Emirates Not on file
Soria, United Arab Emirates Not on file
OLVEGA, Spain Not on file
Soria, Spain Not on file
Olvega, Spain Not on file
Spain, Spain 3008190361

Filings and GMP by regulator

Regulator Filings GMP certificates
ARCSA (EC) 7 None
EFDA (ET) 4 None
NAFDAC (NG) 4 1
INVIMA (CO) 3 None
DIGEMAPS (DO) 3 None
MINSA (CR) 3 None
ANVISA (Brazil) None 1
AEMPS (ES) None 1
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Cyndea Pharma, S.L comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 10 March 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates